Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
This article was originally published in The Tan Sheet
Executive Summary
Bayer could receive a warning letter for its Aspirin with Heart Advantage OTC/supplement combination product if the agency maintains its historic hard line on combining nonprescription drugs with supplements